Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
Many patients with systemic autoimmune rheumatic diseases (SARDs) require
immunosuppression to reduce disease activity, but this also has important possible …
immunosuppression to reduce disease activity, but this also has important possible …
COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance
SYS Tan, AM Yee, JJL Sim, CC Lim - Rheumatology, 2023 - academic.oup.com
Objectives COVID-19 infection is associated with significant morbidity in systemic lupus
erythematosus but is potentially preventable by vaccination, although the impact of the …
erythematosus but is potentially preventable by vaccination, although the impact of the …
[HTML][HTML] Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
RM Dayam, JC Law, RL Goetgebuer, GYC Chao… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Limited information is available on the impact of immunosuppressants on
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID) …
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID) …
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: a cohort study
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
Breakthrough SARS–CoV‐2 Infections in Patients With Immune‐Mediated Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis
CM Calabrese, E Kirchner, EM Husni… - Arthritis & …, 2022 - Wiley Online Library
Objective Patients with immune‐mediated inflammatory diseases (IMIDs) receiving B cell–
depleting therapy (BCDT) are among the most vulnerable to severe COVID‐19, as well as …
depleting therapy (BCDT) are among the most vulnerable to severe COVID‐19, as well as …
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational …
L Seekircher, Z Bánki, J Kimpel, A Rössler… - The Lancet …, 2023 - thelancet.com
Background Correlates of protection could help to assess the extent to which a person is
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection) …
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection) …
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel …
TG Skaria, A Sreeprakash, R Umesh… - The Lancet …, 2022 - thelancet.com
Background There is a necessity for an optimal COVID-19 vaccination strategy for
vulnerable population groups, including people with autoimmune inflammatory arthritis on …
vulnerable population groups, including people with autoimmune inflammatory arthritis on …
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and …
V Furer, T Eviatar, T Freund, H Peleg… - Annals of the …, 2022 - ard.bmj.com
Objectives To evaluate long-term kinetics of the BNT162b2 mRNA vaccine-induced immune
response in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and …
response in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and …
Covid‐19 vaccination in autoimmune rheumatic diseases: a multi‐center survey from southern India
K Mohanasundaram, S Santhanam… - International Journal …, 2022 - Wiley Online Library
Aim This survey was conducted to evaluate COVID‐19 vaccination status in patients with
autoimmune rheumatic diseases (AIRDs). Our objectives were to study vaccine hesitancy …
autoimmune rheumatic diseases (AIRDs). Our objectives were to study vaccine hesitancy …